Executive Director, Medical Director- Diabetes

Executive Medical Director - Endocrinology Compensation: $300,000-336,000 + bonus + RSU's Company Summary: We're partnering with a mid-sized biotech leading the way in endocrine, orphan lung, and cardiorenal therapeutics. With multiple FDA-approved products, the company is scaling rapidly and building on a strong foundation of commercial success. What makes this opportunity compelling is the combination of proven impact and continued growth. The organization has demonstrated the ability to meaningfully improve patients' lives today, challenging the idea that you need to be working on something entirely novel to have real clinical impact. Here, the focus is on delivering therapies that are effective, accessible, and truly change the day-to-day experience for patients. At the same time, the pipeline continues to expand across internal programs and strategic partnerships, providing exposure across early development, lifecycle management, and portfolio-level decision-making. This creates an environment where a clinical leader can operate beyond execution, shaping strategy, influencing program direction, and contributing to the long-term build of the organization. If you're motivated by driving clinically meaningful programs, working with validated science, and stepping into a role with both strategic visibility and real impact, we'd welcome the opportunity to connect and share more. Primary Responsibilities: Lead clinical development across Cardiorenal programs, serving as the senior clinical authority and representing the therapeutic area in executive and portfolio decision-making Drive integrated clinical strategy by translating scientific, clinical, and competitive insights into development plans, prioritization, and long-range portfolio strategy Partner with the CMO to shape and execute heart failure and broader Cardiorenal clinical development strategy aligned with enterprise goals Lead design of Phase 1-4 trials, including dose selection, patient segmentation, biomarkers, and endpoint strategy, ensuring scientific rigor and regulatory alignment Engage internal experts and external KOLs to refine study design, strengthen scientific rationale, and ensure programs reflect real-world practice and unmet need Oversee execution of clinical programs across all phases, ensuring high-quality, efficient delivery across cross-functional teams including Clinical Ops, Biostats, Data Management, and Translational Medicine Lead safety strategy and pharmacovigilance oversight, including signal detection, risk-benefit assessment, and maintaining accountability for medical monitoring Ensure compliance with global regulatory requirements (FDA, EMA, GCP) and inspection readiness Lead regulatory strategy and key submissions (INDs, NDAs/BLAs, briefing documents, CSRs) and represent the therapeutic area in global health authority interactions Partner with Medical Affairs to align clinical development with scientific communication and evidence generation, supporting publication strategy and external engagement Guide interpretation and communication of clinical data, integrating emerging scientific and competitive insights to refine strategy and inform executive decision-making Partner cross-functionally with Commercial, Market Access, and Business Development to ensure evidence supports differentiation, access, and portfolio expansion; support diligence and partnership activities Contribute to governance, pipeline prioritization, and resource planning, including TA budgeting and resourcing Serve as a senior leader within the organization, mentoring teams, supporting talent development, and contributing to broader medical leadership strategy Ideal Qualifications: 3+ years clinical development and/or medical affairs experience in industry. M.D. required, with clinical training and practice experience preferred, ideally within endocrinology. #J-18808-Ljbffr EPM Scientific